Sharing a personal anecdote, columnist G Shellye Horowitz discusses a potential bleeding risk that develops weeks after a ...

Severe haemophilia-A is usually managed with factor-VIII protein replacement or hemostatic products that prevent bleeding. A senior scientist at Bhubaneswar-based Institute of Life Sciences (ILS ...

Patients are born with a genetic defect that means they do not produce a protein needed to stop bleeding ... his body could not make clotting factor VIII. A minor injury used to cause severe ...